HH
GHDX

HWG Holdings’s Genomic Health, Inc. GHDX Stock Holding History

HWG Holdings’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-49
Closed -$2K – 125
2017
Q2 		$2K Buy
+49
New +$1.55K ﹤0.01% 90
2016
Q1 		– Sell
-78,462
Closed -$2.76M – 48
2015
Q4 		$2.76M Buy
+78,462
New +$2.1M 2.81% 18

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

HWG Holdings's GHDX Position: Q3 2017 in Review

HWG Holdings sold out of Genomic Health, Inc. (GHDX) in Q3 2017, closing a stake of 49 shares — an estimated $2K sold.

HWG Holdings first reported a position in GHDX in Q4 2015 and held it in 2 quarters. The position peaked at $2.76M in Q4 2015. 134 funds tracked by Wall St. Rank hold GHDX as of Q3 2017.

  • HWG Holdings reported no remaining Genomic Health, Inc. position as of Q3 2017 after selling out during the quarter.
  • HWG Holdings sold 49 Genomic Health, Inc. shares in Q3 2017, an estimated $2K.
  • HWG Holdings first reported a position in Genomic Health, Inc. in Q4 2015 and held it in 2 quarters.
  • HWG Holdings's Genomic Health, Inc. position peaked at $2.76M in Q4 2015.
  • 134 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2017.

Based on HWG Holdings's 13F filing for Q3 2017, filed 14 Nov 2017.